| For: | González-González R, López-Verdín S, Lavalle-Carrasco J, Molina-Frechero N, Isiordia-Espinoza M, Carreón-Burciaga RG, Bologna-Molina R. Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review. World J Clin Oncol 2020; 11(1): 31-42 [PMID: 31976308 DOI: 10.5306/wjco.v11.i1.31] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i1/31.htm |
| Number | Citing Articles |
| 1 |
Reinhard Buettner, Sibel Elif Gültekin. Molecular diagnostics in odontogenic tumors. Die Pathologie 2022; 43(S1) doi: 10.1007/s00292-022-01152-7
|
| 2 |
Armin Nejat Dehkordi, Moein Maddahi, Parinaz Vafa, Nasim Ebrahimi, Amir Reza Aref. Salivary biomarkers: a promising approach for predicting immunotherapy response in head and neck cancers. Clinical and Translational Oncology 2024; 27(5) doi: 10.1007/s12094-024-03742-8
|
| 3 |
Hongyi Adrian Shi, Chee Wee Benjamin Ng, Chong Teck Kwa, Qiu Xia Chelsia Sim. Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies. The Surgeon 2021; 19(4) doi: 10.1016/j.surge.2020.06.009
|
| 4 |
Neda Kardouni Khoozestani, Farzaneh Mosavat, Mohammad Shirkhoda, Ramtin Azar, Leandro Napier de Souza. Ameloblastic Carcinoma with Calcification: A Rare Case Report in the Mandible and Literature Review. Case Reports in Dentistry 2020; 2020(1) doi: 10.1155/2020/4216489
|
| 5 |
Biswajit Jena, Sanjay Saxena, Gopal Krishna Nayak, Antonella Balestrieri, Neha Gupta, Narinder N. Khanna, John R. Laird, Manudeep K. Kalra, Mostafa M. Fouda, Luca Saba, Jasjit S. Suri. Brain Tumor Characterization Using Radiogenomics in Artificial Intelligence Framework. Cancers 2022; 14(16) doi: 10.3390/cancers14164052
|
| 6 |
Andy W. K. Yeung, Michael M. Bornstein. The Future Circle of Healthcare. Future of Business and Finance 2022; doi: 10.1007/978-3-030-99838-7_22
|
| 7 |
Nicholas E. Koutrakis, Daria Vasilyeva, Joel M. Friedman. Mandibular radiolucency in an 11-year-old girl. The Journal of the American Dental Association 2023; 154(6) doi: 10.1016/j.adaj.2022.05.007
|
| 8 |
Monica B. Kowalski, Leib Y. Wiener, Daria Vasilyeva. Maxillary radiolucency in a 54-year-old man. The Journal of the American Dental Association 2025; 156(9) doi: 10.1016/j.adaj.2024.09.013
|
| 9 |
Arindam Malakar, V. Raj Kumar, Priya Yadav, Vishal Bhardwaj, Chuimee Gogoi Barua, Gourika Bhardwaj. The Role of BRAF Inhibitors in the Management of Ameloblastoma: A Literature Review. Cureus 2023; doi: 10.7759/cureus.47682
|
| 10 |
Wen Li, Yang Li, Xiaoling Liu, Li Wang, Wenqian Chen, Xueshen Qian, Xianglong Zheng, Jiang Chen, Yiming Liu, Lisong Lin. Machine learning-based radiomics for predicting BRAF-V600E mutations in ameloblastoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1180908
|
| 11 |
Markus Hoffmann, Lothar Hennighausen. Spotlight on amino acid changing mutations in the JAK-STAT pathway: from disease-specific mutation to general mutation databases. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-90788-5
|
| 12 |
Allan Vinícius Martins‐de‐Barros, Raíssa Soares dos Anjos, Caio César Gonçalves Silva, Emanuel Dias de Oliveira e Silva, Fábio Andrey da Costa Araújo, Marianne de Vasconcelos Carvalho. Diagnostic accuracy of immunohistochemistry compared with molecular tests for detection of BRAF V600E mutation in ameloblastomas: Systematic review and meta‐analysis. Journal of Oral Pathology & Medicine 2022; 51(3) doi: 10.1111/jop.13278
|
| 13 |
Gustavo de Souza Vieira, Pâmella de Pinho Montovani, Rafaela Elvira Rozza-de-Menezes, Karin Soares Gonçalves Cunha, Danielle Castex Conde. Comparative Analysis Between Dentinogenic Ghost Cell Tumor and Ghost Cell Odontogenic Carcinoma: A Systematic Review. Head and Neck Pathology 2021; 15(4) doi: 10.1007/s12105-021-01347-z
|
| 14 |
Ashutosh Kumar Singh, Ragavi Alagarsamy, Rajib Chaulagain, Abanish Singh, Dipak Sapkota, Selvam Thavaraj, Rabindra P. Singh. Does BRAF mutation status and related clinicopathological factors affect the recurrence rate of ameloblastoma? A systematic review, meta‐analysis and metaregression. Journal of Oral Pathology & Medicine 2023; 52(10) doi: 10.1111/jop.13494
|
| 15 |
Ramakant Dandriyal, Vishakha Lal, Kolli Yada Giri, Niranjanaprasad Indra Bavanthabettu, Archana Chaurasia, Swati Pant. Ameloblastoma: Retrospective Study and Analysis of 102 Cases Over 10 Years, Single Centre, Institutional Experience. Journal of Maxillofacial and Oral Surgery 2022; 21(2) doi: 10.1007/s12663-022-01694-6
|
| 16 |
Constanza Marin, Manas Dave, Keith D. Hunter. Malignant Odontogenic Tumours: A Systematic Review of Cases Reported in Literature. Frontiers in Oral Health 2021; 2 doi: 10.3389/froh.2021.775707
|
| 17 |
Lucas Alves da Mota Santana, John Lennon Silva Cunha, Eduardo Morato de Oliveira, Mark John Santana Sabey, Erika Rezende‐Silva, Liane Maciel de Almeida Souza, Cleverson Luciano Trento. BRAFV600E expression in ameloblastomas: Report of two cases. Oral Surgery 2022; 15(3) doi: 10.1111/ors.12586
|
| 18 |
Yaqi Huang, LinLin Ren, Kit Man Audrey Chau, Zhengnuo Yao, Gan Xiong, Jinqi Zhang, Yingmeng Liu, Cheng Wang. Development and validation of a nomogram for predicting recurrence risk in pediatric ameloblastoma treated with conservative surgery. BMC Oral Health 2026; 26(1) doi: 10.1186/s12903-026-07944-0
|
| 19 |
Yitong Lv, Ziqing Yang, Ziying Pan, Xinwei Liu, Jingze Yu, Bingsong Li, Fenghe Zhang. Advances in MAPK pathway-targeted therapy for ameloblastoma: A literature review. Journal of Stomatology Oral and Maxillofacial Surgery 2026; 127(5) doi: 10.1016/j.jormas.2026.102829
|
| 20 |
Waheed Awotoye, Joseph Craig Whitt, Byunggil Yoo, Midhat S. Farooqi, Emily G. Farrow, Veerasathpurush Allareddy, Brad A. Amendt, Shankar Rengasamy Venugopalan. Genetic heterogeneity and enrichment of variants in DNA‐repair genes in ameloblastoma. Journal of Oral Pathology & Medicine 2023; 52(3) doi: 10.1111/jop.13410
|
| 21 |
X. Yang, K. Zhou, Y. Tao, S. Ge, W. Shang, K. Song. Treatment efficacy and prognosis of pulmonary metastasizing ameloblastoma: a systematic review. International Journal of Oral and Maxillofacial Surgery 2022; 51(5) doi: 10.1016/j.ijom.2021.07.016
|
| 22 |
Tara Renton, Vinod Patel. Oral surgery: what challenges and opportunities are there on the horizon?. Dental Update 2023; 50(5) doi: 10.12968/denu.2023.50.5.422
|
| 23 |
Peiyin Sun, Shuai Wang, Yali Wang, Zheng Wei. Ameloblastoma Diagnosis From Serum Metabolic Profiling. Oral Diseases 2025; 31(8) doi: 10.1111/odi.15308
|
| 24 |
Lucrezia Togni, Antonio Zizzi, Roberta Mazzucchelli, Andrea Santarelli, Corrado Rubini, Marco Mascitti. Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis. International Journal of Oral Science 2022; 14(1) doi: 10.1038/s41368-022-00170-8
|
| 25 |
Bhaskar Narayan, Somesh Kumar, Priya Kumar, Aadithya B. Urs. “Is it time for personalised medicine for Ameloblastoma?”: A hypothesis. Journal of Oral and Maxillofacial Pathology 2023; 27(4) doi: 10.4103/jomfp.jomfp_356_23
|
| 26 |
Haiyang Li, Li Yang, Yali Hou, Yanning Zhang, Yunyi Cui, Xiangjun Li. Potential involvement of polycystins in the pathogenesis of ameloblastomas: Analysis based on bioinformatics and immunohistochemistry. Archives of Oral Biology 2023; 149 doi: 10.1016/j.archoralbio.2023.105662
|
| 27 |
Takuya SHIMOOKA, Takenobu WADA, Jung Soo CHO, Ayaka HUJIWARA, Yudai MATSUOKA, Susumu TANAKA. A case of peripheral ameloblastic carcinoma of the maxilla. Japanese Journal of Oral and Maxillofacial Surgery 2025; 71(4) doi: 10.5794/jjoms.71.187
|
| 28 |
Molecular-targeted therapy in ameloblastoma: a systematic review. Archives of Craniofacial Surgery 2025; 26(4) doi: 10.7181/acfs.2025.0018
|
| 29 |
Zhao Zhang, Ye Peng, Jingyi Dang, Xincheng Liu, Dongze Zhu, Yushen Zhang, Yubo Shi, Hongbin Fan. Identification of key biomarkers related to epithelial‐mesenchymal transition and immune infiltration in ameloblastoma using integrated bioinformatics analysis. Oral Diseases 2023; 29(4) doi: 10.1111/odi.14173
|
| 30 |
Kanankira A. Nnko, Raphael T. Pima, Calvin Baraka, Enock A. Robi, Deogratius S. Rwakatema, Alex Mremi. Surgical management of mandibular ameloblastoma and immediate reconstruction with iliac crest and costochondrial bone grafts: A case report. International Journal of Surgery Case Reports 2024; 121 doi: 10.1016/j.ijscr.2024.110023
|
| 31 |
Anton Raemy, Laurence May, Nathalie Sala, Manuel Diezi, Maja Beck-Popovic, Martin Broome. Anti-MAPK Targeted Therapy for Ameloblastoma: Case Report with a Systematic Review. Cancers 2024; 16(12) doi: 10.3390/cancers16122174
|
| 32 |
Reshma Poothakulath Krishnan, Deepak Pandiar. Mandibular Ameloblastic Carcinoma: A Case Report and Insight into Pathogenesis. Journal of Maxillofacial and Oral Surgery 2024; doi: 10.1007/s12663-024-02411-1
|
| 33 |
Maria Giulia Cristofaro, Ida Barca, Angelo R. Sottile, Francesco Ferragina. Ameloblastic Carcinoma: A 40-Year Scoping Review of the Literature. Current Issues in Molecular Biology 2025; 47(4) doi: 10.3390/cimb47040261
|
| 34 |
Ao‐Bo Zhang, Jian‐Yun Zhang, Yu‐Ping Liu, Shuo Wang, Jia‐Ying Bai, Li‐Sha Sun, Tie‐Jun Li. Clinicopathological characteristics and diagnostic accuracy of BRAF mutations in ameloblastoma: A Bayesian network analysis. Journal of Oral Pathology & Medicine 2024; 53(6) doi: 10.1111/jop.13542
|
| 35 |
Konstantinos Kapriniotis, Angelina Bania, Savvas Lampridis, Georgios Geropoulos, Sofoklis Mitsos, Fleur Monk, David A. Moore, Nikolaos Panagiotopoulos. Metastatic mandibular ameloblastoma of the lung ten years after primary resection: A rare case report. Monaldi Archives for Chest Disease 2021; 91(2) doi: 10.4081/monaldi.2021.1643
|
| 36 |
Marilena Vered, John M. Wright. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Odontogenic and Maxillofacial Bone Tumours. Head and Neck Pathology 2022; 16(1) doi: 10.1007/s12105-021-01404-7
|
| 37 |
Arghavan Etebarian, Samira Derakhshan, Mohammadreza Babaeikia, Hossein Borhani. Handbook of Oral and Maxillofacial Surgery and Implantology. 2025; doi: 10.1007/978-3-031-36962-9_119-2
|
| 38 |
Hidenori Suzuki, Eiichi Sasaki, Ryota Nakamura, Michi Sawabe, Sumitaka Hagiwara, Ikuo Hyodo, Nobuhiro Hanai. Recurrent ameloblastoma with both hypercalcemia and BRAF mutation: A case report. Clinical Case Reports 2020; 8(12) doi: 10.1002/ccr3.3443
|
| 39 |
Keith Hunter, Merva Soluk Tekkesin. Pathological Basis of Oral and Maxillofacial Diseases. 2025; doi: 10.1002/9781119989233.ch32
|
| 40 |
Rebeca Vieira Costa, Karolyny Martins Balbinot, Gabriela Cristina Avertano Rocha da Silveira, Maria Sueli da Silva Kataoka, Silvio Augusto Fernandes de Menezes, Vanessa Morais Freitas, Ana Carolina Uchoa Vasconcelos, Adriana Etges, Victor Angelo Martins Montalli, Fabricio Passador Santos, Sérgio de Melo Alves Júnior, Ruy Gastaldoni Jaeger, João de Jesus Viana Pinheiro. Prognostic value of the expression and localization of cell proliferation and apoptosis markers in unicystic ameloblastomas. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-54132-7
|
| 41 |
Arghavan Etebarian, Samira Derakhshan, Mohammadreza Babaiekia, Hossein Borhani. Handbook of Oral and Maxillofacial Surgery and Implantology. 2024; doi: 10.1007/978-3-031-36962-9_119-1
|
| 42 |
Alieh Farshbaf, Reza Zare, Farnaz Mohajertehran, Nooshin Mohtasham. New diagnostic molecular markers and biomarkers in odontogenic tumors. Molecular Biology Reports 2021; 48(4) doi: 10.1007/s11033-021-06286-0
|
| 43 |
Dragana Gabrić, Roko Bjelica, Mato Sušić, Marko Vuletić. Bone Tumours - A Comprehensive Review of Selected Topics. 2023; doi: 10.5772/intechopen.107403
|
| 44 |
Yuichi EHARA, Koshuke NAGANAWA, Akira UKAI, Yuka MIYAMOTO, Kazuhiro WATANABE, Yasunori MURAMATSU. A case of ameloblastic carcinoma with BRAFV600E mutation. Japanese Journal of Oral and Maxillofacial Surgery 2023; 69(4) doi: 10.5794/jjoms.69.197
|
| 45 |
Allan Vinícius Martins‐de‐Barros, Caio César Gonçalves Silva, Kalyne Kelly Negromonte Gonçalves, Renata de Albuquerque Cavalcanti Almeida, Emanuel Dias de Oliveira e Silva, Fábio Andrey da Costa Araújo, Liam Robinson, Willie F. P. van Heerden, Marianne de Vasconcelos Carvalho. Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta‐analysis. Journal of Oral Pathology & Medicine 2023; 52(8) doi: 10.1111/jop.13458
|
| 46 |
Kien Ai Hoang, Chi Thi Kim Nguyen, Chuong Quoc Ho, Tram Bich Duong, Thao Thi Thu Luu, Tam Thi Thanh Bui, Nam Cong Nhat Huynh, Hoang Anh Vu, Tuyen Dac Vo. BRAF and RAS mutations in Vietnamese patients with ameloblastoma. BMC Oral Health 2026; 26(1) doi: 10.1186/s12903-026-08325-3
|